Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Consolidative Radioimmunotherapy after Chemoimmunotherapy in Patients with Histologic Transformation of Indolent Lymphoma

Patrick M. Reagan, MD, Jennifer L. Kelly, PhD MPH, Andrea Baran, MS, Paul M. Barr, MD, Carla Casulo, MD, Vaseem Chengazi, MD PhD, Jonathan W. Friedberg, MD MMSc

Blood (2014) 124 (21): 1746.

https://doi.org/10.1182/blood.V124.21.1746.1746

Published: 2014

Journal Articles

Natural History of Transformed Non-Hodgkin Lymphoma in the Rituximab Era: Analysis of the National Comprehensive Cancer Network (NCCN) NHL Outcomes Database.

Makiko Ban-Hoefen, MD, Ann Vanderplas, MS, Jennifer L. Kelly, PhD, MPH, Allison Crosby-Thompson, Gregory A. Abel, MD, MPH, Myron S. Czuczman, MD, Leo I. Gordon, MD, Mark S. Kaminski, MD, Michael Millenson, MD, Auayporn Nademanee, MD, Maria A. Rodriguez, MD, Andrew D. Zelenetz, MD, PhD, Joyce Niland, PhD, Ann LaCasce, MD, Jonathan W. Friedberg, MD

Blood (2012) 120 (21): 2669.

https://doi.org/10.1182/blood.V120.21.2669.2669

Published: 2012

Journal Articles

Low Serum Vitamin D Levels Are Associated with Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and Lysa Studies.

Jennifer L. Kelly, PhD, MPH, Gilles Salles, MD, Bryan H. Goldman, MS, Richard I Fisher, MD, Olivier Casasnovas, Oliver W. Press, MD, PhD, David G. Maloney, MD, PhD, Pierre Soubeyran, Lisa M. Rimsza, MD, Michael LeBlanc, PhD, Herve Tilly, MD, Jonathan W. Friedberg, MD

Blood (2012) 120 (21): 2712.

https://doi.org/10.1182/blood.V120.21.2712.2712

Published: 2012

Journal Articles

Impact of Obesity and Genetic Variation in Energy Balance and Metabolism Genes On Prognosis in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

James M. Foran, MD, FRCPC, Cristine Allmer, BS, Alice H Wang, BA, Carrie A. Thompson, MD, Jennifer L. Kelly, PhD, MPH, Grzegorz S. Nowakowski, MD, Matthew J Maurer, MS, Susan L Slager, PhD, David J. Inwards, MD, Stephen M. Ansell, M.D., Ph.D., Thomas E. Witzig, MD, Brian K Link, MD, Thomas M Habermann, MD, James R Cerhan, MD, PhD

Blood (2012) 120 (21): 684.

https://doi.org/10.1182/blood.V120.21.684.684

Published: 2012

Journal Articles

Comprehensive in Vitro and in Vivo Analysis of Phosphatidylinositol-3-Kinase Delta (PI3Kδ) Inhibition Using GS-1101 (CAL-101) in Combination with Mammalian Target of Rapamycin (mTOR) Inhibition Using Temsirolimus or Everolimus in Mantle Cell Lymphoma (MCL)

Paul M. Barr, MD, Francisco J. Hernandez-Ilizaliturri, MD, Thomas Murante, BS, Shannon P. Hilchey, PhD, Derick R Peterson, PhD, Jennifer L. Kelly, PhD, MPH, Dave M. Johnson, Brian J. Lannutti, PhD, Myron S. Czuczman, MD, Jonathan W. Friedberg, MD, Steven H. Bernstein, MD

Blood (2012) 120 (21): 3719.

https://doi.org/10.1182/blood.V120.21.3719.3719

Published: 2012

Journal Articles

Health-Related Quality of Life in Older Patients Following Diffuse Large B-Cell Lymphoma (DLBCL) Diagnosis

Jennifer L. Kelly, PhD, MPH, Chintan Pandya, MD MPH, Jonathan W. Friedberg, MD, Supriya G. Mohile, MD

Blood (2012) 120 (21): 4287.

https://doi.org/10.1182/blood.V120.21.4287.4287

Published: 2012

Journal Articles

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma

Jonathan W. Friedberg, Julie M. Vose, Jennifer L. Kelly, Faith Young, Steven H. Bernstein, Derick Peterson, Lynn Rich, Susan Blumel, Nicole K. Proia, Jane Liesveld, Richard I. Fisher, James O. Armitage, Steven Grant, John P. Leonard

Blood (2011) 117 (10): 2807–2812.

https://doi.org/10.1182/blood-2010-11-314708

Published: 2011

Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Makiko Ban-Hoefen, MD, Jonathan W. Friedberg, MD, Jennifer L. Kelly, PhD, MPH, Steven H. Bernstein, MD, Jane L. Liesveld, MD, Faith Young, MD, Richard I Fisher, MD, Louis Constine, MD, Michael Becker, MD, Gordon L. Phillips, II, MD

Blood (2010) 116 (21): 2393.

https://doi.org/10.1182/blood.V116.21.2393.2393

Published: 2010

Journal Articles

Vitamin D Deficiency Is Associated with Inferior Event-Free and Overall Survival in Diffuse Large B-Cell Lymphoma.

Matthew T Drake, MD, PhD, Matthew J Maurer, MS, Brian K Link, MD, Ivana N Micallef, MD, Thomas M Habermann, MD, Jennifer L Kelly, PhD, MPH, William R Macon, MD, Daniel Nikcevich, MD, Joseph P Colgan, MD, Cristine Allmer, BS, Susan L Slager, PhD, George J Weiner, MD, Thomas E Witzig, MD, James R Cerhan, MD, PhD

Blood (2009) 114 (22): 1952.

https://doi.org/10.1182/blood.V114.22.1952.1952

Published: 2009

Journal Articles

Germline Variation in Apoptosis Pathway Genes and Risk of Non-Hodgkin Lymphoma.

Jennifer L Kelly, PhD, MPH, Anne J Novak, PhD, Zachary S Fredericksen, Mark Liebow, Stephen M Ansell, Ahmet Dogan, PhD, Alice H. Wang, Thomas E Witzig, MD, Timothy G Call, MD, Neil E. Kay, MD, Thomas M Habermann, MD, Susan L Slager, PhD, James R Cerhan, MD, PhD

Blood (2009) 114 (22): 3933.

https://doi.org/10.1182/blood.V114.22.3933.3933

Published: 2009

Journal Articles

Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial.

Jonathan W. Friedberg, MD, Julie M. Vose, M.D., Jennifer L Kelly, PhDMPH, Faith Young, MD, Jane Liesveld, MD, James O. Armitage, M.D., Nicole Proia, MPH, Kim Cruttenden, N.P., John P. Leonard, MD

Blood (2009) 114 (22): 924.

https://doi.org/10.1182/blood.V114.22.924.924

Published: 2009

Journal Articles

Vitamin D, Sun Exposure, and Lymphoma Risk.

Jennifer L. Kelly, PhD, MPH, Jonathan W. Friedberg, MD, MMSc, Laura M. Calvi, MD, Edwin van Wijngaarden, PhD, Susan G. Fisher, MS, PhD

Blood (2008) 112 (11): 1783.

https://doi.org/10.1182/blood.V112.11.1783.1783

Published: 2008

NARROW

Consolidative Radioimmunotherapy after Chemoimmunotherapy in Patients with Histologic Transformation of Indolent Lymphoma

Natural History of Transformed Non-Hodgkin Lymphoma in the Rituximab Era: Analysis of the National Comprehensive Cancer Network (NCCN) NHL Outcomes Database.

Low Serum Vitamin D Levels Are Associated with Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and Lysa Studies.

Impact of Obesity and Genetic Variation in Energy Balance and Metabolism Genes On Prognosis in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

Comprehensive in Vitro and in Vivo Analysis of Phosphatidylinositol-3-Kinase Delta (PI3Kδ) Inhibition Using GS-1101 (CAL-101) in Combination with Mammalian Target of Rapamycin (mTOR) Inhibition Using Temsirolimus or Everolimus in Mantle Cell Lymphoma (MCL)

Health-Related Quality of Life in Older Patients Following Diffuse Large B-Cell Lymphoma (DLBCL) Diagnosis

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Vitamin D Deficiency Is Associated with Inferior Event-Free and Overall Survival in Diffuse Large B-Cell Lymphoma.

Germline Variation in Apoptosis Pathway Genes and Risk of Non-Hodgkin Lymphoma.

Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial.

Vitamin D, Sun Exposure, and Lymphoma Risk.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only